Silence Therapeutics plc Shareholders' Equity
Silence Therapeutics plc (SLNCF) had Shareholders' Equity of $38.47 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $38.47M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $49.40M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $62.30M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $74.06M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $38.47M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $49.40M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $62.30M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $74.06M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $94.16M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $112.74M 10-Q · filed 2026-08-10 |
| 2024-12-31 | $134.02M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $126.70M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $142.53M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $156.76M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $21.99M 10-K · filed 2026-03-05 |
| 2022-12-31 | $27.22M 10-K · filed 2025-02-27 |
| 2021-12-31 | $12.37M 10-K · filed 2025-02-27 |